Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mustang Bio Announces First Subject Treated in CD20-targeted CAR T Cell Therapy MB-106 Trial

americanpharmaceuticalreviewMarch 10, 2020

Tag: MB-106 , Mustang Bio , Fred Hutchinson Cancer Research Center

PharmaSources Customer Service